Perspective Therapeutics, Inc. (CATX)
NYSEAMERICAN: CATX · IEX Real-Time Price · USD
1.810
+0.080 (4.62%)
At close: May 3, 2024, 4:00 PM
1.840
+0.030 (1.66%)
After-hours: May 3, 2024, 4:41 PM EDT

Perspective Therapeutics Revenue

In the year 2023, Perspective Therapeutics had annual revenue of $1.43M. Revenue in the quarter ending December 31, 2023 was $-4.90M with 185.50% year-over-year growth.

Revenue (ttm)
$1.43M
Revenue Growth
-126.65%
P/S Ratio
728.53
Revenue / Employee
$12,362
Employees
116
Market Cap
1.06B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.43M--
Jun 30, 20220--
Jun 30, 202110.05M373.00K3.85%
Jun 30, 20209.68M2.37M32.35%
Jun 30, 20197.31M1.39M23.48%
Jun 30, 20185.92M1.16M24.41%
Jun 30, 20174.76M-8.00K-0.17%
Jun 30, 20164.77M163.00K3.54%
Jun 30, 20154.61M386.84K9.17%
Jun 30, 20144.22M-306.08K-6.76%
Jun 30, 20134.53M-545.86K-10.76%
Jun 30, 20125.07M-167.89K-3.20%
Jun 30, 20115.24M-47.11K-0.89%
Jun 30, 20105.29M-131.73K-2.43%
Jun 30, 20095.42M-1.74M-24.32%
Jun 30, 20087.16M1.42M24.76%
Jun 30, 20075.74M3.74M187.72%
Jun 30, 20061.99M1.79M888.60%
Jun 30, 2005201.73K--
Sep 30, 20040--
Sep 30, 20030--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Alignment Healthcare 2.01B
AtriCure 414.60M
MiMedx Group 334.51M
Cronos Group 87.24M
Immatics 60.00M
Arcutis Biotherapeutics 59.61M
EyePoint Pharmaceuticals 46.02M
Bicycle Therapeutics 41.61M
Revenue Rankings